Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Circadian Technologies Ltd (ASX: CIR)

 
CIR Technical Analysis
4
As on 11th Dec 2015 CIR Share Price closed @ 0.31 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.19 & Buy for SHORT-TERM with Stoploss of 0.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CIR Share Price

Open 0.30 Change Price %
High 0.31 1 Day 0.00 0.00
Low 0.30 1 Week 0.00 0.00
Close 0.31 1 Month 0.00 0.00
Volume 70000 1 Year 0.00 0.00
52 Week High 33.50 | 52 Week Low 30.51
 
ASX Australia Most Active Stocks
COE 0.30 3.45%
GPP 0.02 0.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
BPT 1.05 7.14%
PNX 0.01 0.00%
PIO 0.03 0.00%
DJS 3.99 0.00%
KSO 0.40 3900.00%
 
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
XST 0.02 100.00%
XST 0.02 100.00%
ATP 0.03 50.00%
ATP 0.03 50.00%
PMQ 0.03 50.00%
RMI 0.03 50.00%
RMI 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
 
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
GDY 0.01 -50.00%
 
 
CIR
Daily Charts		 CIR
Intraday Charts		 Whats New @
Bazaartrend		 CIR
Free Analysis
 
CIR Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.32
RESISTANCE0.32
SUPPORT0.30
SUPPORT0.30
SUPPORT0.00
SUPPORT0.00
 
CIR Target for Month September
Share
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
CIR Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
CIR Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
CIR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website >
 
CIR Address
CIR
 650 Chapel Street
Suite 0403
South Yarra, VIC 3141
Australia
Phone: 61 3 9826 0399
Fax: 61 3 9824 0083
 
CIR Latest News
 
Your Comments and Response on Circadian Technologies Ltd
 
CIR Business Profile
Circadian Technologies Limited develops and commercializes therapies for cancer and eye diseases in Australia. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and R3 targets. The company’s product pipeline includes anti-VEGFR-3 antibody that is in Phase I clinical trials for the treatment of solid tumours; VGX-100, a human antibody against VEGF-C, as a treatment for lymphedema resulting from breast cancer treatment and solid tumours; and VGX-300, a soluble form of VEGFR-3 for ‘back of the eye’ disease. It also develops diagnostic test products for cancers of unknown primaries; and blood based diagnostic tests for VEGF-C and VEGF-D as predictive and prognostic tests in lymphangioleiomyomatosis and cancer patients. The company is based in South Yarra, Australia.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service